150 related articles for article (PubMed ID: 37865134)
1. Diselenium-linked dimeric prodrug nanomedicine breaking the intracellular redox balance for triple-negative breast cancer targeted therapy.
Chen M; Zhang M; Lu X; Li Y; Lu C
Eur J Pharm Biopharm; 2023 Dec; 193():16-27. PubMed ID: 37865134
[TBL] [Abstract][Full Text] [Related]
2. Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy.
He X; Zhang J; Li C; Zhang Y; Lu Y; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Guo Q; Sun T; Cheng J; Jiang C
Theranostics; 2018; 8(18):4884-4897. PubMed ID: 30429875
[TBL] [Abstract][Full Text] [Related]
3. Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.
He X; Cai K; Zhang Y; Lu Y; Guo Q; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Li C; Sun T; Cheng J; Jiang C
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39455-39467. PubMed ID: 30362704
[TBL] [Abstract][Full Text] [Related]
4. Breaking the Intracellular Redox Balance with Diselenium Nanoparticles for Maximizing Chemotherapy Efficacy on Patient-Derived Xenograft Models.
Wei D; Yu Y; Zhang X; Wang Y; Chen H; Zhao Y; Wang F; Rong G; Wang W; Kang X; Cai J; Wang Z; Yin JY; Hanif M; Sun Y; Zha G; Li L; Nie G; Xiao H
ACS Nano; 2020 Dec; 14(12):16984-16996. PubMed ID: 33283501
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its Reparation.
Huang Z; Xian T; Meng X; Hu H; Gao L; Huang J; Yang D; Ou K; Wang B; Zhang Y
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836815
[TBL] [Abstract][Full Text] [Related]
6. Photo-responsive prodrug nanoparticles for efficient cytoplasmic delivery and synergistic photodynamic-chemotherapy of metastatic triple-negative breast cancer.
Jiao J; Lu H; Wang S
Acta Biomater; 2021 May; 126():421-432. PubMed ID: 33774201
[TBL] [Abstract][Full Text] [Related]
7. Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier.
Ma W; Sun J; Xu J; Luo Z; Diao D; Zhang Z; Oberly PJ; Minnigh MB; Xie W; Poloyac SM; Huang Y; Li S
Theranostics; 2020; 10(6):2463-2478. PubMed ID: 32194813
[TBL] [Abstract][Full Text] [Related]
8. A Paclitaxel Prodrug with Copper Depletion for Combined Therapy toward Triple-Negative Breast Cancer.
Hao D; Meng Q; Li C; Lu S; Xiang X; Pei Q; Jing X; Xie Z
ACS Nano; 2023 Jul; 17(13):12383-12393. PubMed ID: 37322575
[TBL] [Abstract][Full Text] [Related]
9. Cascade-amplified self-immolative polymeric prodrug for cancer therapy by disrupting redox homeostasis.
Dey A; Jeon J; Yoon B; Li Y; Park JH
J Control Release; 2023 Jun; 358():555-565. PubMed ID: 37182804
[TBL] [Abstract][Full Text] [Related]
10. Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
Kou L; Sun R; Xiao S; Zheng Y; Chen Z; Cai A; Zheng H; Yao Q; Ganapathy V; Chen R
ACS Appl Mater Interfaces; 2019 Jul; 11(30):26722-26730. PubMed ID: 31276364
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyethyl starch-folic acid conjugates stabilized theranostic nanoparticles for cancer therapy.
Wang C; Wang Q; Wang H; Li Z; Chen J; Zhang Z; Zeng H; Yu X; Yang X; Yang X; Li Z
J Control Release; 2023 Jan; 353():391-410. PubMed ID: 36473606
[TBL] [Abstract][Full Text] [Related]
12. A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy.
Wang Y; Zhang Y; Ru Z; Song W; Chen L; Ma H; Sun L
J Nanobiotechnology; 2019 Aug; 17(1):91. PubMed ID: 31451114
[TBL] [Abstract][Full Text] [Related]
13. Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities.
Zuo S; Sun B; Yang Y; Zhou S; Zhang Y; Guo M; Sun M; Luo C; He Z; Sun J
Small; 2020 Nov; 16(45):e2005039. PubMed ID: 33078579
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine Targeting Cuproplasia in Cancer: Labile Copper Sequestration Using Polydopamine Particles Blocks Tumor Growth
Bonet-Aleta J; Encinas-Gimenez M; Oi M; Pezacki AT; Sebastian V; de Martino A; Martín-Pardillos A; Martin-Duque P; Hueso JL; Chang CJ; Santamaria J
ACS Appl Mater Interfaces; 2024 Jun; 16(23):29844-29855. PubMed ID: 38829261
[TBL] [Abstract][Full Text] [Related]
15. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
16. A Novel Polyamino Acid Sulfur Dioxide Prodrug Synergistically Elevates ROS with β-Lapachone in Cancer Treatment.
Tang B; Zhang Y; Liu X; Wang Y; He P
J Pharm Sci; 2024 May; 113(5):1239-1247. PubMed ID: 38042342
[TBL] [Abstract][Full Text] [Related]
17. Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress.
Zhao H; Li Y; Shi H; Niu M; Li D; Zhang Z; Feng Q; Zhang Y; Wang L
J Control Release; 2022 Dec; 352():909-919. PubMed ID: 36370878
[TBL] [Abstract][Full Text] [Related]
18. A Mitochondria-Targeted Ferroptosis Inducer Activated by Glutathione-Responsive Imaging and Depletion for Triple Negative Breast Cancer Theranostics.
Gan H; Huang X; Luo X; Li J; Mo B; Cheng L; Shu Q; Du Z; Tang H; Sun W; Wang L; Luo S; Yu S
Adv Healthc Mater; 2023 Sep; 12(22):e2300220. PubMed ID: 37204240
[TBL] [Abstract][Full Text] [Related]
19. ROS-cleavable diselenide nanomedicine for NIR-controlled drug release and on-demand synergistic chemo-photodynamic therapy.
Zhu R; He Q; Li Z; Ren Y; Liao Y; Zhang Z; Dai Q; Wan C; Long S; Kong L; Fan W; Yu W
Acta Biomater; 2022 Nov; 153():442-452. PubMed ID: 36179978
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeting oxidative stress nanoamplifiers as anticancer nanomedicine with immunostimulating activity.
Song N; Park M; Kim N; Lee Y; Jung E; Lee D
Biomater Sci; 2022 Oct; 10(21):6160-6171. PubMed ID: 36222413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
